New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas

QR Code

New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas

Head and neck squamous cell carcinoma (HNSCC) is one of the most frequent types of cancer with a lethal outcome in half of the diagnosed cases. Mostly, HNSCC develops in the oral cavity, and its development is associated with tobacco and areca nut/betel quid usage, alcohol consumption, and HPV infec...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Cristina Porcheri, Thimios A. Mitsiadis
Format:	article
Langue:	EN
Publié:	MDPI AG 2021
Sujets:	head and neck squamous cell carcinoma oral cancer drug testing drug delivery organoids spheroids Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/20cdbf784bbd421bbf3b0fa1bee49e72
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
par: He Jian, et autres
Publié: (2021)

Oral and Oropharyngeal Squamous Cell Carcinoma in Our Population: The Clinic-Pathological and Morphological Description of 153 Cases
par: Agarwal,A. K, et autres
Publié: (2011)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
par: Farzaneh Kordbacheh, et autres
Publié: (2021)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
par: Lucrezia Togni, et autres
Publié: (2021)

Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma
par: Song C, et autres
Publié: (2020)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
par: Xuanli Xu, et autres
Publié: (2021)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
par: Fu L, et autres
Publié: (2021)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
par: Karl Payne, et autres
Publié: (2021)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
par: Philipp Baumeister, et autres
Publié: (2021)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
par: Hayashi N, et autres
Publié: (2021)

Roles of mesenchymal stromal cells in the head and neck cancer microenvironment
par: Marcelo Coutinho de Miranda, et autres
Publié: (2021)

Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma
par: Will OM, et autres
Publié: (2016)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
par: Ammar Sukari, et autres
Publié: (2015)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
par: Qian X, et autres
Publié: (2021)

Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
par: Galo Méndez-Matías, et autres
Publié: (2021)

The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth
par: Hassan CE, et autres
Publié: (2016)

Imaging Features of Postradiotherapy Changes in Head and Neck Cancers
par: Anisha Gehani, et autres
Publié: (2021)

Rare Metastasis to the Submandibular Gland in Oral Squamous Cell Carcinoma
par: Ping Zhou, et autres
Publié: (2021)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
par: Shinsuke Suzuki, et autres
Publié: (2021)

The Hidden Link of Exosomes to Head and Neck Cancer
par: Yong Teng, et autres
Publié: (2021)

Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?
par: Iago Ferreira, et autres
Publié: (2021)

Clinicopathological Profile of Oral Squamous Cell Carcinoma in Eastern India
par: Surendra Nath Senapati, et autres
Publié: (2021)

Acantholytic Squamous Cell Carcinoma
par: Sandy Maganito, et autres
Publié: (2021)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
par: Xinwen Wang, et autres
Publié: (2021)

Targeting miR-185-3p Inhibits Head and Neck Squamous Cell Carcinoma by Modulating RAB25
par: Xueping Wang, et autres
Publié: (2021)

A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma
par: Xiaolei Gao, et autres
Publié: (2021)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
par: Xing-xing Huo, et autres
Publié: (2021)

Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma
par: Gunnar Wichmann, et autres
Publié: (2021)

Review of oncological findings and complications after elective neck dissection during total laryngectomy: a case series
par: Mahmoud Elsayed, et autres
Publié: (2021)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
par: Pei-Hung Chang, et autres
Publié: (2021)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
par: Ying-Peng Peng, et autres
Publié: (2021)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
par: Jerry Polesel, et autres
Publié: (2021)

Treatment Outcomes and the Safety of Chemoradiotherapy With High-Dose CDDP for Elderly Patients With Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Study
par: Jo Omata, et autres
Publié: (2021)

Immunohistochemical Analysis of the Beclin-1 Expression Predicts the Progression of Oral Squamous Cell Carcinoma
par: Ida Barca, et autres
Publié: (2021)

Late Diagnosis of Oral Melanoma
par: Santana,Lucas Alves da Mota, et autres
Publié: (2019)

Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer—A Systematic Review
par: Markéta Hudečková, et autres
Publié: (2021)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
par: Qi Sun, et autres
Publié: (2021)

A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
par: Re-I Chin, et autres
Publié: (2021)

Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy
par: Loredana G. Marcu, et autres
Publié: (2021)

The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
par: Enhao Wang, et autres
Publié: (2021)